Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
Kai‐Christian Sonntag, Bin Song, Nayeon Lee, et al.
Progress in Neurobiology (2018) Vol. 168, pp. 1-20
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease
Jeffrey S. Schweitzer, Bin Song, Todd Herrington, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 20, pp. 1926-1932
Open Access | Times Cited: 410
Reversing a model of Parkinson’s disease with in situ converted nigral neurons
Hao Qian, Xinjiang Kang, Jing Hu, et al.
Nature (2020) Vol. 582, Iss. 7813, pp. 550-556
Open Access | Times Cited: 406
α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesis
Surabhi Mehra, Shruti Sahay, Samir K. Maji
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2019) Vol. 1867, Iss. 10, pp. 890-908
Closed Access | Times Cited: 357
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
Daisuke Doi, Hiroaki Magotani, Tetsuhiro Kikuchi, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 260
Advancement in the modelling and therapeutics of Parkinson’s disease
Sachchida Nand, Payal Singh
Journal of Chemical Neuroanatomy (2020) Vol. 104, pp. 101752-101752
Closed Access | Times Cited: 163
Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models
Bin Song, Young Cha, Sanghyeok Ko, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 2, pp. 904-920
Open Access | Times Cited: 145
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview
Farzane Sivandzade, Luca Cucullo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2153-2153
Open Access | Times Cited: 145
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease
Tae Yoon Park, Jeha Jeon, Nayeon Lee, et al.
Nature (2023) Vol. 619, Iss. 7970, pp. 606-615
Closed Access | Times Cited: 64
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives
Ramyar Rahimi Darehbagh, Seyedeh Asrin Seyedoshohadaei, Rojin Ramezani, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 20
Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues
Soo Jin Park, Yoon Young Kim, Ji Yeon Han, et al.
Tissue Engineering and Regenerative Medicine (2024) Vol. 21, Iss. 3, pp. 379-394
Open Access | Times Cited: 18
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
Jeha Jeon, Young Cha, Yean Ju Hong, et al.
Cell stem cell (2025)
Closed Access | Times Cited: 2
Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders
Caroline Vissers, Guo‐li Ming, Hongjun Song
Advanced Drug Delivery Reviews (2019) Vol. 148, pp. 239-251
Open Access | Times Cited: 118
Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease
Young Cha, Tae Yoon Park, Pierre Leblanc, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 1, pp. 22-41
Open Access | Times Cited: 26
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease
Sang Hyun Park, Chan Wook Park, Jang Hyeon Eom, et al.
Cell stem cell (2023) Vol. 31, Iss. 1, pp. 25-38.e8
Open Access | Times Cited: 26
A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects
Mauricio Muleiro Álvarez, Gabriela Cano-Herrera, María Fernanda Osorio Martínez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7183-7183
Open Access | Times Cited: 15
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Tae Yoon Park, Jeha Jeon, Young Cha, et al.
Cell Research (2024) Vol. 34, Iss. 7, pp. 479-492
Open Access | Times Cited: 9
Drug repositioning for Parkinson’s disease: an emphasis on artificial intelligence approaches
Iman Karimi-Sani, Mehrdad Sharifi, Nahid Abolpour, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102651-102651
Closed Access | Times Cited: 1
Induced pluripotent stem cells, a giant leap for mankind therapeutic applications
José Bragança, João A. Lopes, Leonardo Mendes-Silva, et al.
World Journal of Stem Cells (2019) Vol. 11, Iss. 7, pp. 421-430
Open Access | Times Cited: 65
Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations
Manon Desgres, Philippe Menasché
Cell stem cell (2019) Vol. 25, Iss. 5, pp. 594-606
Open Access | Times Cited: 64
Stem Cell-Based Therapies for Parkinson Disease
Zhaohui Liu, Hoi‐Hung Cheung
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8060-8060
Open Access | Times Cited: 64
The Function of Astrocyte Mediated Extracellular Vesicles in Central Nervous System Diseases
Tahereh Gharbi, Zhijun Zhang, Guo-Yuan Yang
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 62
Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis
Fang Wang, Zhengwu Sun, Daoyong Peng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
New implications for prion diseases therapy and prophylaxis
Fangzhou Liu, Wenqi Lü, Ling Liu
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells
Emilía Sif Ásgrímsdóttir, Ernest Arenas
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 40
Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease
Julio Águila, Shangli Cheng, Nigel Kee, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top